News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
58,173 Results
Type
Article (2503)
Company Profile (30)
Press Release (55640)
Multimedia
Podcasts (2)
Webinars (2)
Section
Business (18083)
Career Advice (109)
Deals (3152)
Drug Delivery (3)
Drug Development (5460)
Employer Resources (13)
FDA (1551)
Job Trends (1881)
News (28187)
Policy (1846)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (2)
Academia (292)
Accelerated approval (4)
Allergies (6)
Alliances (4857)
ALS (9)
Alzheimer's disease (145)
Antibody-drug conjugate (ADC) (33)
Approvals (1641)
Artificial intelligence (88)
Autoimmune disease (20)
Automation (11)
Bankruptcy (16)
Best Places to Work (1794)
BIOSECURE Act (1)
Biosimilars (20)
Biotechnology (18)
Bladder cancer (39)
Brain cancer (7)
Breast cancer (53)
Cancer (519)
Cardiovascular disease (34)
Career advice (102)
Career pathing (3)
CAR-T (25)
Cell therapy (91)
Cervical cancer (7)
Clinical research (5097)
Collaboration (271)
Compensation (41)
Complete response letters (1)
COVID-19 (72)
CRISPR (15)
C-suite (249)
Cystic fibrosis (10)
Data (667)
Denatured (1)
Depression (11)
Diabetes (75)
Diagnostics (870)
Digital health (6)
Diversity, equity & inclusion (3)
Drug discovery (32)
Drug pricing (2)
Duchenne muscular dystrophy (28)
Earnings (4378)
Editorial (2)
Employer branding (1)
Employer resources (13)
Events (7755)
Executive appointments (287)
FDA (1975)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (345)
Gene editing (27)
Generative AI (8)
Gene therapy (108)
GLP-1 (50)
Government (288)
Guidances (48)
Healthcare (2302)
Huntington's disease (3)
IgA nephropathy (8)
Immunology and inflammation (19)
Immuno-oncology (3)
Indications (15)
Infectious disease (82)
Inflammatory bowel disease (13)
Influenza (2)
Intellectual property (16)
Interviews (21)
IPO (1155)
Job creations (194)
Job search strategy (75)
JPM (5)
Labor market (1)
Layoffs (19)
Leadership (8)
Legal (225)
Liver cancer (9)
Longevity (4)
Lung cancer (70)
Lymphoma (49)
Machine learning (11)
Management (6)
Manufacturing (103)
MASH (8)
Medical device (1796)
Medtech (1806)
Mergers & acquisitions (2178)
Metabolic disorders (115)
Multiple sclerosis (34)
Neurodegenerative disease (32)
Neuropsychiatric disorders (3)
Neuroscience (269)
Neurotech (1)
NextGen: Class of 2026 (818)
Non-profit (810)
Obesity (27)
Opinion (19)
Ovarian cancer (11)
Pain (13)
Pancreatic cancer (13)
Parkinson's disease (20)
Partnered (4)
Patents (19)
Patient recruitment (66)
Peanut (1)
People (8639)
Pharmaceutical (11)
Phase 1 (1358)
Phase 2 (2024)
Phase 3 (2150)
Pipeline (591)
Policy (5)
Postmarket research (239)
Preclinical (442)
Press Release (7)
Prostate cancer (23)
Psychedelics (1)
Radiopharmaceuticals (28)
Rare diseases (86)
Real estate (443)
Recruiting (6)
Regulatory (1795)
Reports (1)
Research institute (328)
Resumes & cover letters (12)
Rett syndrome (1)
Schizophrenia (8)
Series A (75)
Series B (54)
Service/supplier (1)
Sickle cell disease (13)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (539)
Supply chain (15)
The Weekly (1)
Vaccines (35)
Venture capital (12)
Weight loss (14)
Women's health (11)
Worklife (2)
Date
Today (3)
Last 7 days (55)
Last 30 days (224)
Last 365 days (3499)
2026 (343)
2025 (3583)
2024 (3869)
2023 (4524)
2022 (6021)
2021 (5731)
2020 (5147)
2019 (5354)
2018 (3827)
2017 (2687)
2016 (2568)
2015 (2537)
2014 (1827)
2013 (1355)
2012 (1290)
2011 (1326)
2010 (1143)
Location
Africa (57)
Alabama (10)
Alaska (3)
Arizona (37)
Arkansas (4)
Asia (3929)
Australia (520)
California (1215)
Canada (312)
China (140)
Colorado (32)
Connecticut (23)
Delaware (48)
Europe (8091)
Florida (149)
Georgia (86)
Hawaii (3)
Idaho (10)
Illinois (102)
India (9)
Indiana (80)
Iowa (9)
Japan (65)
Kansas (10)
Kentucky (1)
Louisiana (4)
Maine (2)
Maryland (129)
Massachusetts (845)
Michigan (62)
Minnesota (46)
Mississippi (1)
Missouri (18)
Montana (4)
Nebraska (3)
Nevada (27)
New Hampshire (11)
New Jersey (343)
New Mexico (3)
New York (344)
North Carolina (234)
North Dakota (3)
Northern California (613)
Ohio (38)
Oklahoma (4)
Oregon (11)
Pennsylvania (266)
Puerto Rico (1)
Rhode Island (10)
South America (64)
South Carolina (7)
Southern California (418)
Tennessee (63)
Texas (186)
United States (4585)
Utah (57)
Virginia (60)
Washington D.C. (9)
Washington State (193)
West Virginia (2)
Wisconsin (15)
58,173 Results for "notal vision".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioMark: 2025 Achievements & 2026 Vision
Celebrating A Year of Extraordinary Achievement
January 2, 2026
·
7 min read
Press Releases
First Patient Treated in Myra Vision’s U.S. ADAPT Clinical Study for Glaucoma
January 27, 2026
·
3 min read
Press Releases
Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors
December 16, 2025
·
4 min read
Press Releases
Blood Cancer United Showcases Bold Research and Vision at 2025 ASH Annual Meeting
December 2, 2025
·
7 min read
Press Releases
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
·
3 min read
Press Releases
BioRegenx, Inc. (OTC: BRGX) Announces Major Corporate Progress, Auditor Transition, Technology Integration, and AI-Driven Strategic Vision
December 10, 2025
·
5 min read
Press Releases
mRNA Therapeutics Market Size to Attain USD 45.04 Billion by 2034 | Vision Research Reports
November 13, 2025
·
1 min read
Press Releases
NurExone Demonstrates Reproducible, Dose-Dependent Vision Recovery in Preclinical Glaucoma Model
October 9, 2025
·
13 min read
Press Releases
Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss
October 20, 2025
·
7 min read
Press Releases
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
October 20, 2025
·
13 min read
1 of 5,818
Next
